Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management
- 3 January 1999
- journal article
- research article
- Published by Elsevier BV in Atherosclerosis
- Vol. 142 (1), 105-112
- https://doi.org/10.1016/s0021-9150(98)00200-7
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Influence of specific mutations at the LDL-receptor gene locus on the response to simvastatin therapy in Afrikaner patients with heterozygous familial hypercholesterolaemiaAtherosclerosis, 1993
- Cholesterol and heart disease in older persons and women review of an NHLBI workshopAnnals of Epidemiology, 1992
- Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group.BMJ, 1991
- Cardiovascular disease risk profilesAmerican Heart Journal, 1991
- Relation of Serum Lipoprotein(a) Concentration and Apolipoprotein(a) Phenotype to Coronary Heart Disease in Patients with Familial HypercholesterolemiaThe New England Journal of Medicine, 1990
- Familial hypercholesterolemia and apolipoprotein E4Atherosclerosis, 1988
- Mortality and cholesterol metabolism in familial hypercholesterolemia. Long-term follow-up of 96 patients.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988
- Family similarities in the age at coronary death in familial hypercholesterolaemia.BMJ, 1977
- Coronary Artery Disease in 116 Kindred with Familial Type II HyperlipoproteinemiaCirculation, 1974
- Coronary Disease in Familial HypercholesterolemiaCirculation, 1967